|
(V1248) |
Identification of Circulating MicroRNAs as Potential Novel Biomarkers for Clinical Outcome in Patients with ST-Elevation Myocardial Infarction |
| |
|
P. Jakob, D. Heg, R. Klingenberg, N. Rodondi, P. Vogt, F. Mach, C. Matter, S. Windecker, T. F. Lüscher, U. Landmesser , SPUM-ACS (Berlin, Bad Nauheim; Bern, Lausanne, Genf, Zürich, CH) |
|
|
Diskussion |
|
(V1249) |
Evidence of an interaction between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in human platelets |
| |
|
D. Rath, M. Chatterjee, A. Holtkamp, N. Tekath, O. Borst, S. Vogel, K. A. L. Müller, M. Gawaz, T. Geisler (Tübingen) |
|
|
Diskussion |
|
(V1250) |
Peripheral blood mononuclear cell miR-34a levels are associated with subclinical atherosclerosis and incident coronary artery disease |
| |
|
R. Achangwa, K. Stamatelopoulos, F. F. Lunella, A. Mareti, C. Kritsioti, N. Makris, S. Kapatsori, C. Amrhein, A. Gatsiou, A. M. Zeiher, S. Dimmeler, K. Stellos (Frankfurt am Main; Athens, GR) |
|
|
Diskussion |
|
(V1251) |
Immune mediators IL-10 and TNF-alpha as a potential diagnostic tool for detection of advanced coronary artery disease in transplanted heart. |
| |
|
C. Bara, B. Przybylek, A. Neumann, A. Haverich, C. Falk (Hannover) |
|
|
Diskussion |
|
(V1252) |
Hypoxische Hepatitis im infarktbedingten kardiogenen Schock - eine IABP-SHOCK II Biomarker Substudie |
| |
|
C. Jung, G. Fürnau, S. Desch, I. Eitel, M. Kelm, G. C. Schuler, V. Adams, H. Thiele (Düsseldorf, Lübeck, Leipzig) |
|
|
Diskussion |
|
(V1253) |
Definition of the new indicators number needed to rule out (NNRO) and number needed for correct diagnosis (NNCD) to define the diagnostic ability of novel biomarkers |
| |
|
L. Palapies, E. Herrmann, J. Oppermann, T. Zeller, S. Blankenberg, T. Münzel, A. M. Zeiher, T. Keller (Frankfurt am Main, Hamburg, Mainz) |
|
|
Diskussion |